Abstract CT124: First-in-human study of SC-004, an antibody-drug conjugate targeting CLDN6/9, in patients with epithelial ovarian cancers
Year: 2020
Type: conference-abstract
Source: Cancer Research
Authors: Erika Hamilton, Gini F. Fleming, Premal H. Thaker, Vivek Subbiah, Chris Chen, Abraham Fong, Daniel Brickman, Kathleen Moore
Institutions: Sarah Cannon, Tennessee Oncology, University of Chicago, University of Chicago Medical Center, Washington University in St. Louis, The University of Texas MD Anderson Cancer Center, OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, University of Oklahoma
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3082358734